Comment on Mathieu et al. Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab

Sigurd Lenzen

Abstract

Comment on Mathieu et al. Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab --- Source: OpenAlex - Diabetes Care (Citations: 1) PDF: https://diabetesjournals.org/care/article-pdf/49/11/e194/898982/dc261221.pdf Original Link: https://doi.org/https://doi.org/10.2337/dc26-1221

Submitted: October 30, 2026Subjects: Open Science; Focus (optics)

Description / Details

Comment on Mathieu et al. Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab

Source: OpenAlex - Diabetes Care (Citations: 1) PDF: https://diabetesjournals.org/care/article-pdf/49/11/e194/898982/dc261221.pdf Original Link: https://doi.org/https://doi.org/10.2337/dc26-1221

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper

View Source PDF

Submission Info

Date:
Oct 30, 2026

Topic:
Focus (optics)

Area:
Open Science

Comments:
0

Bookmark

Comment on Mathieu et al. Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab | Researchia | Researchia